26 results
F-3
EX-1.2
CMMB
Chemomab Therapeutics Ltd
16 Oct 23
Shelf registration (foreign)
4:25pm
of Expenses. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including (i) the preparation … and the registrar for the Ordinary Shares or the ADSs (x) the filing and other fees incident to any review by FINRA of the terms of the sale
424B3
r5wpmkaniuw1m
29 Apr 21
Prospectus supplement
6:10am
S-3
dmkej8t83p9ha
15 Apr 21
Shelf registration
4:03pm
8-K
EX-10.1
vr5weku
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
S-4
EX-2.1
9q9ihe gs06ptk6pqw4
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.6
4sdqn
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.7
hh9m 9rapgqp9gz6nh
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
EX-2.1
i41pbtbwqu74aw2u
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-2.1
f8l 8dkfqt
15 Dec 20
Additional proxy soliciting materials
3:32pm
6-K
EX-1.1
8gvqwfesbq5ti7bn6c
14 Feb 19
Current report (foreign)
4:40pm
424B4
ojo1k7 n21t9
13 Feb 19
Prospectus supplement with pricing info
8:20am
F-1/A
xc4m1u
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
5hhz3g7ypium mw
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-1.1
bz9umvi
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
EX-1.1
nguujv7hqvm0ekytp2o
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-10.2
z7oox2jc58nowgyo
7 Jan 19
Registration statement (foreign)
5:11pm